This study found that CA50, CA242, and SAA exhibited higher specificity in prognostic stratification (CA50 and CA242 both at 88.37%, SAA at 83.72%), effectively reducing interference from benign diseases and providing a more reliable basis for risk stratification. This evidence concerns the gene SAA1 and neoplasm.